Barrett, J. H., Sheehan N. A., Cox, A., Worthington, J., Cannings, C., Teare, M.D. (2007)
Family based studies and genetic epidemiology: theory and practice.
Human Heredity 64:146-148.

http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=
17476114&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum

Bishop, J. N., Harland, M., Randerson-Moor, J., and Bishop, D. T. (2007).
Management of familial melanoma.
Lancet Oncol 8(1), 46-54.

http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=
17196510&ordinalpos=5&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum

Bishop, J. N., Bataille, V., Gavin, A., Lens, M., Marsden, J., Mathews, T., and Wheelhouse, C. (2007).
The prevention, diagnosis, referral and management of melanoma of the skin: concise guidelines.
Clin Med 7(3), 283-90.

Bishop, J. A., Taylor, T., Potts, H. W., Elliott, F., Pinney, E., Barrett, J. H., Bishop, D. T., and Fallowfield, L. (2007).
Sun-protective behaviors in families at increased risk of melanoma.
J Invest Dermatol 127(6), 1343-50.

Goldstein, A. M., Chan, M., Harland, M., Hayward, N. K., Demenais, F., Bishop, D. T., Azizi, E., Bergman, W., Bianchi-Scarra, G., Bruno, W., Calista, D., Albright, L. A., Chaudru, V., Chompret, A., Cuellar, F., Elder, D. E., Ghiorzo, P., Gillanders, E. M., Gruis, N. A., Hansson, J., Hogg, D., Holland, E. A., Kanetsky, P. A., Kefford, R. F., Landi, M. T., Lang, J., Leachman, S. A., MacKie, R. M., Magnusson, V., Mann, G. J., Bishop, J. N., Palmer, J. M., Puig, S., Puig-Butille, J. A., Stark, M., Tsao, H., Tucker, M. A., Whitaker, L., and Yakobson, E. (2007).
Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents.
J Med Genet 44(2), 99-106.

Pjanova, D., Engele, L., Randerson-Moor, J. A., Harland, M., Bishop, D. T., Newton Bishop, J. A., Taylor, C., Debniak, T., Lubinski, J., Kleina, R., and Heisele, O. (2007).
CDKN2A and CDK4 variants in Latvian melanoma patients: analysis of a clinic-based population.
Melanoma Res 17(3), 185-91.

Seminara, D., Khoury, M. J., O'Brien, T. R., Manolio, T., Gwinn, M. L., Little, J., Higgins, J. P., Bernstein, J. L., Boffetta, P., Bondy, M., Bray, M. S., Brenchley, P. E., Buffler, P. A., Casas, J. P., Chokkalingam, A. P., Danesh, J., Davey Smith, G., Dolan, S., Duncan, R., Gruis, N. A., Hashibe, M., Hunter, D., Jarvelin, M. R., Malmer, B., Maraganore, D. M., Newton-Bishop, J. A., Riboli, E., Salanti, G., Taioli, E., Timpson, N., Uitterlinden, A. G., Vineis, P., Wareham, N., Winn, D. M., Zimmern, R., and Ioannidis, J. P. (2007).
The emergence of networks in human genome epidemiology: challenges and opportunities.
Epidemiology 18(1), 1-8.

Strauss, R. M., Elliott, F., Affleck, P., Boon, A. P., Newton-Bishop, J. A. (2007)
A retrospective study addressed to understanding what predicts severe histological dysplasia/early melanoma in excised atypical melanocytic lesions.
Br J Dermatol. 157(4): 758-764.

Bishop, J. N., Harland, M., and Bishop, D. T. (2006).
The genetics of melanoma.
Br J Hosp Med (Lond) 67(6), 299-304.

Goldstein, A. M., Chan, M., Harland, M., Gillanders, E. M., Hayward, N. K., Avril, M. F., Azizi, E., Bianchi-Scarra, G., Bishop, D. T., Bressac-de Paillerets, B., Bruno, W., Calista, D., Cannon Albright, L. A., Demenais, F., Elder, D. E., Ghiorzo, P., Gruis, N. A., Hansson, J., Hogg, D., Holland, E. A., Kanetsky, P. A., Kefford, R. F., Landi, M. T., Lang, J., Leachman, S. A., Mackie, R. M., Magnusson, V., Mann, G. J., Niendorf, K., Newton Bishop, J., Palmer, J. M., Puig, S., Puig-Butille, J. A., de Snoo, F. A., Stark, M., Tsao, H., Tucker, M. A., Whitaker, L., and Yakobson, E. (2006).
High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL.
Cancer Res 66(20), 9818-28.

Ioannidis, J. P., Gwinn, M., Little, J., Higgins, J. P., Bernstein, J. L., Boffetta, P., Bondy, M., Bray, M. S., Brenchley, P. E., Buffler, P. A., Casas, J. P., Chokkalingam, A., Danesh, J., Smith, G. D., Dolan, S., Duncan, R., Gruis, N. A., Hartge, P., Hashibe, M., Hunter, D. J., Jarvelin, M. R., Malmer, B., Maraganore, D. M., Newton-Bishop, J. A., O'Brien, T. R., Petersen, G., Riboli, E., Salanti, G., Seminara, D., Smeeth, L., Taioli, E., Timpson, N., Uitterlinden, A. G., Vineis, P., Wareham, N., Winn, D. M., Zimmern, R., and Khoury, M. J. (2006).
A road map for efficient and reliable human genome epidemiology.
Nat Genet 38(1), 3-5.

Affleck, P. (2005).
The challenge of recruitment.
Nurse Res 13(1), 78-84.

Affleck, P. (2005).
Sun exposure and health.
Nurs Stand 19(47), 50-4.

Butler, J. M., Bishop, D. T., and Barrett, J. H., (2005)
Strategies for selecting subsets of single nucleotide polymorphisms to genotype in association studies.
BMC Genetics, 6(Suppl 1):S72.

Harland, M., Taylor, C. F., Chambers, P. A., Kukalizch, K., Randerson-Moor, J. A., Gruis, N. A., de Snoo, F. A., ter Huurne, J. A., Goldstein, A. M., Tucker, M. A., Bishop, D. T., and Bishop, J. A. (2005).
A mutation hotspot at the p14ARF splice site.
Oncogene 24(28), 4604-8.

Harland, M., Taylor, C. F., Bass, S., Churchman, M., Randerson-Moor, J. A., Holland, E. A., Mann, G. J., Bishop, D. T., and Newton Bishop, J. A. (2005).
Intronic sequence variants of the CDKN2A gene in melanoma pedigrees.
Genes Chromosomes Cancer 43(2), 128-36.

Jackson, S., Harland, M., Turner, F., Taylor, C., Chambers, P. A., Randerson-Moor, J., Swerdlow, A. J., dos Santos Silva, I., Beswick, S., Bishop, D. T., and Newton Bishop, J. A. (2005).
No Evidence for BRAF as a melanoma/nevus susceptibility gene.
Cancer Epidemiol Biomarkers Prev 14(4), 913-8.

Mistry, S. H., Taylor, C., Randerson-Moor, J. A., Harland, M., Turner, F., Barrett, J. H., Whitaker, L., Jenkins, R. B., Knowles, M. A., Bishop, J. A., and Bishop, D. T. (2005).
Prevalence of 9p21 deletions in UK melanoma families.
Genes Chromosomes Cancer 44(3), 292-300.

Molven, A., Grimstvedt, M. B., Steine, S. J., Harland, M., Avril, M. F., Hayward, N. K., and Akslen, L. A. (2005).
A large Norwegian family with inherited malignant melanoma, multiple atypical nevi, and CDK4 mutation.
Genes Chromosomes Cancer 44(1), 10-8.

Newton Bishop, J. A., and Bishop, D. T. (2005).
The genetics of susceptibility to cutaneous melanoma.
Drugs Today (Barc) 41(3), 193-203.

Teare, M. D., and Barrett, J. H. (2005)
Genetic linkage studies.
Lancet 366: 1036-1044.

Wachsmuth, R. C., Turner, F., Barrett, J. H., Gaut, R., Randerson-Moor, J. A., Bishop, D. T., and Bishop, J. A. (2005).
The effect of sun exposure in determining nevus density in UK adolescent twins.
J Invest Dermatol 124(1), 56-62.

Lens, M. B., Rosdahl, I., Ahlbom, A., Farahmand, B. Y., Synnerstad, I., Boeryd, B., and Newton Bishop, J. A. (2004).
Effect of pregnancy on survival in women with cutaneous malignant melanoma.
J Clin Oncol 22(21), 4369-75.

Randerson-Moor, J. A., Gaut, R., Turner, F., Whitaker, L., Barrett, J. H., Silva Idos, S., Swerdlow, A., Bishop, D. T., and Bishop, J. A. (2004).
The relationship between the epidermal growth factor (EGF) 5'UTR variant A61G and melanoma/nevus susceptibility.
J Invest Dermatol 123(4), 755-9.

Bertram CG, Gaut RM, Barrett JH, Randerson-Moor J, Whitaker L, Turner F, Bataille V, dos Santos Silva I, Swedlow AJ, Bishop DT, Newton Bishop JA.
An assessment of a variant of the DNA repair gene XRCC3 as a possible nevus or melanoma susceptibility genotype.
J Invest Dermatol 2004 122 (2):429-432

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15009726

Newton Bishop JA, Nolan C, Turner F, McCabe M, Boxer C, Merion Thomas J, Coombes G, A'Hern RPA, Barrett JH.
A quality of life study in high-risk (thickness >=or 2mm) cutaneous melanoma patients in a randomized trial of 1cm versus 3cm surgical excision margins.
J Invest Dermatol Symp Proc 2004 Mar;9(2):152-9

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15083783

Thomas JM, Newton Bishop JA, A'Hern R, Coombes G, Evans J, Cook M, Theaker J, Fallowfield M, Timmons M, O'Neill T, Ruka W, Bliss J, on behalf of the UK Melanoma Study Group.
Excision margins in high-risk malignant melanoma.
New Engl J Med 2004 Feb 19; 350(8):757-66

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=14973217

Bataille V, Winnett A, Sasieni P, Newton Bishop JA, Cuzick J
Exposure to the sun and sunbeds and the risk of cutaneous melanoma in the UK: a case-control study.
Eur J Cancer. 2004 Feb;40(30:429-35

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=14746862

Lens MB, Newton Bishop JA, Dawes M
Surgical margins in cutaneous melanoma (2cm versus 5cm for lesions measuring less than 2.1mm thick).
Cancer. 2004 Jan 15;100(2):433-4

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=14716782

Boyle P, Autier P, Bartelink H, Baselga J, Boffetta P, Burn J, Burns HJG, Christensen L, Denis L, Dicato M, Diehl V, Doll R, Franceschi S, Gillis CR, Gray N, Gricuite L, Hackshaw A, Kasler M, Kogevinas M, Kvinnsland S, La Vecchia C, Levi F, McVie JG, Maisonneuve P, Martin-Moreno J, Newton Bishop JA, Oleari F, Perrin P, Richards M, Ringborg U, Siracka E, Quinn M, Storm H, Tubiana M, Tursz T, Veronesi U, Wald N, Weber W, Zaridze DG, Zatonski W, zur Hausen H
European code against cancer Third Version (2003) and scientific justification.
Ann Oncol 2003 Jul;14(7):973-1005

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12853336

Barrett JH, Gaut R, Wachsmuth R, Newton Bishop JA, Bishop DT
Linkage and association analysis of nevus density and the region containing the melanoma gene CDKN2A in a study of UK twins.
Br J Cancer 2003 88:1920-1924

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12799637

Gillanders E, Juo S-HH, Holland EA, Jones M, Nancarrow D, Freas-Lutz D, Sood R, Park N, Faruque M, Markey C, Kefford RF, Palmer J, Bergman W, Bishop DT, Tucker MA, Bressac-de Paillerets B, Hansson J, Stark M, Gruis N, Newton Bishop J, Goldstein AM, Bailey-Wilson J, Mann GJ, Hayward N, Trent J, on behalf of the Melanoma Genetics Consortium
Localization of a Novel Melanoma Susceptibility Locus to 1p22.
Am J Hum Genet 73:301-13, 2003

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12844286

Hoffmann K, Gambichler T, Rick A, Kreutz M, Ansch M, Grnendick T, Orlikov A, Gehlen G, Perotti R, Andreassi L, Newton Bishop J, Sarini J-P, Fischer T, Frosch PJ, Lindskov R, MacKie R, Nashan D, Sommer A, Neumann MHA, Ortonne J-P, Bahadoran P, Penas PF, Zoras U, Altmeyer P
Diagnostic And Neuronal Analysis Of Skin cancer (DANAOS): a multi-center study for collection and capture aided analysis of data from pigmented skin lesions.
Br J Dermatol 2003 Oct;149 (4):801-9

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=14616373

Stefoski Mikeljevic J, Johnston C, Adamson PJ, Wright A, Newton Bishop JA, Batman P, Neal RD, Forman D
How complete has skin cancer registration been in the UK? A study from Yorkshire.
Eur J Cancer Prev 2003 12:125-33

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12671536

Bertram CG, Gaut RM, Barrett JH, Pinney E, Whitaker L, Turner F, Bataille V, Dos Santos Silva I, A JS, Bishop DT, Newton Bishop JA
An assessment of the CDKN2A variant Ala148Thr as a nevus/melanoma susceptibility allele.
J Invest Dermatol 2002 119:961-5

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=1240634

Bishop DT, Demenais F, Goldstein AM, Bergman W, Bishop JN, Bressac-de Paillerets B, Chompret A, Ghiorzo P, Gruis N, Hansson J, Harland M, Hayward N, Holland EA, Mann GJ, Mantelli M, Nancarrow D, Platz A, Tucker MA
Geographical variation in the penetrance of CDKN2A mutations for melanoma.
J Natl Cancer Inst 2002 94:894-903

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12072543

Huot TJ, Rowe J, Harland M, Drayton S, Brookes S, Gooptu C, Purkis P, Fried M, Bataille V, Hara E, Newton-Bishop J, Peters G
Biallelic mutations in p16(INK4a) confer resistance to Ras- and Ets-induced senescence in human diploid fibroblasts.
Mol Cell Biol 2002 22:8135-43

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12417717

Kefford R, Bishop JN, Tucker M, Bressac-de Paillerets B, Bianchi-Scarra G, Bergman W, Goldstein A, Puig S, Mackie R, Elder D, Hansson J, Hayward N, Hogg D, OlssonH
Genetic testing for melanoma.
Lancet Oncol 2002 3:653-4

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12424065

Lens MB, Dawes M, Goodacre T, Bishop JA
Excision margins in the treatment of primary cutaneous melanoma: a systematic review of randomized controlled trials comparing narrow vs wide excision.
Arch Surg 2002 137:1101-5

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12361412

Lens MB, Dawes M, Goodacre T, Newton-Bishop JA
Elective lymph node dissection in patients with melanoma: systematic review and meta-analysis of randomized controlled trials.
Arch Surg 2002 137:458-61

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=11926952

Lens MB, Dawes M, Newton-Bishop JA, Goodacre T
Management of regional lymph nodes in patients with malignant melanoma: questionnaire survey of UK current practice.
Br J Plast Surg 2002 55:372-5

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12372363

Lens MB, Dawes M, Newton-Bishop JA, Goodacre T
Tumour thickness as a predictor of occult lymph node metastases in patients with stage I and II melanoma undergoing sentinel lymph node biopsy.
Br J Surg 2002 89:1223-7

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12296887

Newton Bishop JA, Corrie PG, Evans J, Gore ME, Hall PN, Kirkham N, Roberts DL, Anstey AV, Barlow RJ, Cox NH
Ambiguity in the UK guidelines for the management of cutaneous melanoma: a reply from authors.
Br J Dermatol 2002:836-837
(This is not a PubMed citation)

http://www.blackwell-synergy.com/servlet/useragent?func=synergy&synergyAction=showAbstract&doi=10.1046/j.1365-2133.2002.505223.x&area=production&prevSearch=allfield%3A%28guidelines%29

Newton Bishop JA, Corrie PG, Evans J, Gore ME, Hall PN, Kirkham N, Roberts DL, Anstey AV, Barlow RJ, Cox NH
High dose interferon, sentinel lymph node biopsy and the UK guidelines for cutaneous melanoma: reply from authors.
Br J Dermatol 2002:834-835
(This is not a PubMed citation)

http://www.blackwell-synergy.com/servlet/useragent?func=synergy&synergyAction=showAbstract&doi=10.1046/j.1365-2133.2002.505719.x&area=production&prevSearch=allfield%3A%28High+dose+interferon%29

Newton Bishop JA, Corrie PG, Evans J, Gore ME, Hall PN, Kirkham N, Roberts DL, Anstey AV, Barlow RJ, Cox NH
Staging investigations and the UK guidelines for cutaneous melanoma: reply from authors.
Br J Dermatol 2002:838
(This is not a PubMed citation)

http://www.blackwell-synergy.com/servlet/useragent?func=synergy&synergyAction=showAbstract&doi=10.1046/j.1365-2133.2002.505223.x&area=production&prevSearch=allfield%3A%28staging%29

Newton Bishop JA, Corrie PG, Evans J, Gore ME, Hall PN, Kirkham N, Roberts DL, Anstey AV, Barlow RJ, Cox NH
UK guidelines for the management of cutaneous melanoma.
Br J Plast Surg 2002 55:46-54

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=11783968

Roberts DL, Anstey AV, Barlow RJ, Cox NH, Newton Bishop JA, Corrie PG, Evans J, Gore ME, Hall PN, Kirkham N
U.K. guidelines for the management of cutaneous melanoma.
Br J Dermatol 2002 146:7-17

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=11841361

Harland M, Mistry S, Bishop DT, Bishop JA
A deep intronic mutation in CDKN2A is associated with disease in a subset of melanoma pedigrees.
Hum Mol Genet 2001 10:2679-86

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=11726555

Mahendran RM, Newton-Bishop JA
Survey of U.K. current practice in the treatment of lentigo maligna.
Br J Dermatol 2001 144:71-6

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=11167685

Randerson-Moor JA, Harland M, Williams S, Cuthbert-Heavens D, Sheridan E, Aveyard J, Sibley K, Whitaker L, Knowles M, Bishop JN, Bishop DT
A germline deletion of p14(ARF) but not CDKN2A in a melanoma-neural system tumour syndrome family.
Hum Mol Genet 2001 10:55-62

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=11136714

Wachsmuth RC, Gaut RM, Barrett JH, Saunders CL, Randerson-Moor JA, Eldridge A, Martin NG, Bishop DT, Newton Bishop JA
Heritability and gene-environment interactions for melanocytic nevus density examined in a U.K. adolescent twin study.
J Invest Dermatol 2001 117:348-52

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=11511314

Harland M, Holland EA, Ghiorzo P, Mantelli M, Bianchi-Scarra G, Goldstein AM, Tucker MA, Ponder BA, Mann GJ, Bishop DT, Newton Bishop J
Mutation screening of the CDKN2A promoter in melanoma families.
Genes Chrom Cancer 2000 28:45-57

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=10738302

McWhirter JM, Collins M, Bryant I, Wetton NM, Newton Bishop J
Evaluating 'Safe in the Sun', a curriculum programme for primary schools.
Health Educ Res 2000 15:203-17

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=10751379

Newton Bishop J, Harland M, Wachsmuth R, Pinney E, Bataille V, Whitaker L, Cuzick J, Bishop D
Genotype/phenotype and penetrance studies in melanoma families with germline CDKN2A mutations.
J Invest Dermatol 2000 114:28-33

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=10620111

Newton Bishop JA, Bradburn M, Bergman W, Osterlind A, Pinney E, Rosdahl I, Scerri L, Weichenthal M, Mant D, Breitbart E, Karlsson P, Altman D
Teaching non-specialist health care professionals how to identify the atypical mole syndrome phenotype: a multinational study.
Br J Dermatol 2000 142:331-337

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=10730769

Kefford RF, Newton Bishop JA, Bergman W, Tucker MA
Counseling and DNA testing for individuals perceived to be genetically predisposed to melanoma: A consensus statement of the Melanoma Genetics Consortium.
J Clin Oncol 1999 17:3245-51

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=10506626

Kupsch JM, Tidman NH, Kang NV, Truman H, Hamilton S, Patel N, Newton Bishop JA, Leigh IM, Crowe JS
Isolation of human tumor-specific antibodies by selection of an antibody phage library on melanoma cells.
Clin Cancer Res 1999 5:925-31

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=10213230

Newton Bishop JA, Harland M, Bennett DC, Bataille V, Goldstein AM, Tucker MA, Ponder BA, Cuzick J, Selby P, Bishop DT
Mutation testing in melanoma families: INK4A, CDK4 and INK4D.
Br J Cancer 1999 80:295-300

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=10390011

Thomas MD, Clough K, Melamed MD, Stevenson FK, Chapman CJ, Spellerberg MB, Potter KN, Newton-Bishop JA, Gregson N, Dawson K
A human monoclonal antibody encoded by the V4-34 gene segment recognises melanoma-associated ganglioside via CDR3 and FWR1.
Hum Antibodies 1999 9:95-106

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=10405830

Bataille V, Grulich A, Sasieni P, Swerdlow A, Newton Bishop J, McCarthy W, Hersey P, Cuzick J
The association between naevi and melanoma in populations with different levels of sun exposure: a joint case-control study of melanoma in the UK and Australia.
Br J Cancer 1998 77:505-10

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=9472652

Bataille V, Sasieni P, Grulich A, Swerdlow A, McCarthy W, Hersey P, Newton Bishop JA, Cuzick J
Solar keratoses: a risk factor for melanoma but negative association with melanocytic naevi.
Int J Cancer 1998 78:8-12

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=9724086

Khorshid SM, Pinney E, Bishop JA
Melanoma excision by general practitioners in north-east Thames region, England.
Br J Dermatol 1998 138:412-7

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=9580791

Marshall JF, Rutherford DC, Happerfield L, Hanby A, McCartney AC, Newton-Bishop J, Hart IR
Comparative analysis of integrins in vitro and in vivo in uveal and cutaneous melanomas.
Br J Cancer 1998 77:522-9

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=9484806

Newton Bishop JA, Harland M, Bishop DT
The genetics of melanoma: the UK experience.
Clin Exp Dermatol 1998 23:158-61

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=9894359

Pollock PM, Spurr N, Bishop T, Newton-Bishop J, Gruis N, van der Velden PA, Goldstein AM, Tucker MA, Foulkes WD, Barnhill R, Haber D, Fountain J, Hayward NK
Haplotype analysis of two recurrent CDKN2A mutations in 10 melanoma families: evidence for common founders and independent mutations.
Hum Mutat 1998 11:424-31

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=9603434

Wachsmuth RC, Harland M, Bishop JA
The atypical-mole syndrome and predisposition to melanoma.
N Engl J Med 1998 339:348-9

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=9696648

Wachsmuth RC, Newton Bishop JA, Gaut RM, Barrett JH, Bishop DT (2001)
The influence of genes and environment on nevus density in sun-exposed and sun-protected sites: a study of UK adolescent twins.
Paper presented at IGES

Cancer Research UK
www.cancerresearchuk.org/

University of Leeds
www.leeds.ac.uk/

Leeds Teaching Hospitals NHS Trust
www.leedsth.nhs.uk/

National Cancer Research Network
www.ncrn.org.uk/

British Association of Dermatologists
www.bad.org.uk/about/

Robert Ogden Macmillan Cancer